DUSA up on 2nd Quarter Results
DUSA Pharmaceuticals Inc. (NASDAQ: DUSA) had a positive start this morning, edging up 10 percent to $2.60 a share this morning on the company's recent posting of its second quarter financial results for 2007. According to the results, it looks like things have been fairly good for DUSA. The company reported that total product revenues for the company had increased from $6.6 million to $6.9 million. Revenue on its Levluan photodynamic therapy (PDT) product was also up, climbing to $4.1 million from $3.8 million the year before. Total product revenues for the six months ended June 30, 2007, were $13.5…